Among these, 12 articles, which included 14 sets of studies, evaluated the relationship between TILs and DCIS recurrence, and 6 articles investigated the prognostic value of TIL subtypes (CD4+, CD8+, FOXP3+, PD-L1) in DCIS. Here, CD8A is linked to ductal breast carcinoma in situ.